Memory B cells play a key role in adapting to new coronavirus variants

The SARS-CoV-2 coronavirus is constantly mutating. As a result, vaccines become less effective and need to be regularly adapted. This was the case in 2025 with the JN.1 variant. An interdisciplinary team from Hanover and Göttingen has now investigated how the immune system responds to adapted vaccines. The findings were published in Nature Communications.